Emmaus Life Sciences, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2011 | 77.6% | 77.6% | -2,396.4% |
| FY2012 | 26.1% | 26.1% | -2,718.9% |
| FY2013 | 505.0% | 505.0% | -777.9% |
| FY2014 | 151.2% | 151.2% | -199.3% |
| FY2015 | 69.9% | 69.9% | -595.9% |
| FY2016 | 558.1% | 558.1% | -1,160.1% |
| FY2017 | -38.9% | -38.9% | -116.7% |
| FY2018 | 334.4% | 895.3% | -96.4% |
| FY2019 | 496.2% | 496.2% | -92.2% |
| FY2020 | -26.3% | 13.4% | 2.3% |
| FY2021 | 74.3% | -1,793.7% | -28.1% |
| FY2022 | 31.2% | 289.3% | -22.0% |
| FY2023 | 7.8% | 21.7% | -10.6% |
| FY2024 | 11.4% | 23.5% | -27.3% |
| FY2025 | 11.8% | 20.5% | -35.0% |